Novo Nordisk’s Wegovy wins UK approval for use to reduce heart risks

Novo Nordisk’s Wegovy wins UK approval for use to reduce heart risks

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. 

Nurphoto | Getty Images

LONDON — The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk‘s Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart…

[ad_2]

Source link

More From Author

6 Deadly Food Combinations – WION

6 Deadly Food Combinations – WION

Study assesses therapeutic strategies for severe obesity in adolescents

Study assesses therapeutic strategies for severe obesity in adolescents

Leave a Reply

Your email address will not be published. Required fields are marked *